Ogen and Lenvatinib drug interactions - a phase IV clinical study of FDA data
Summary:
We study 6,140 people who take Ogen (estropipate) and Lenvatinib (lenvatinib). There is no drug interaction reported.
The study analyzes what interactions people have when they take Ogen and Lenvatinib. It is created by eHealthMe based on reports the from the FDA, and is updated regularly.
What is Ogen?
Ogen has active ingredients of estropipate. eHealthMe is studying from 2,553 Ogen users. Check the latest studies of Ogen.
What is Lenvatinib?
Lenvatinib has active ingredients of lenvatinib. eHealthMe is studying from 3,587 Lenvatinib users. Check the latest studies of Lenvatinib.
No report is found.
Do you take Ogen and Lenvatinib?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Ogen (2,553 reports)
- Lenvatinib (3,587 reports)
How the study uses the data?
The study uses data from the FDA. It is based on estropipate and lenvatinib (the active ingredients of Ogen and Lenvatinib, respectively), and Ogen and Lenvatinib (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Depression Aggravated and Ear Barotrauma - 4 seconds ago
- Drug interactions of Claritin-D and Velcade - 10 seconds ago
- Drug interactions of Calcium and Exidine - 11 seconds ago
- How effective is Nasonex for Nasal Congestion? - 12 seconds ago
- Could Kesimpta cause Bedwetting? - 14 seconds ago
- Could Bactrim cause Posture Abnormal? - 21 seconds ago
- Drug interactions of Savella and Ampyra - 25 seconds ago
- Could Melphalan cause Haematuria Aggravated? - 27 seconds ago
- Drug interactions of Egrifta and Hydroxyzine - 28 seconds ago
- Drug interactions of Wellbutrin Xl and Aromasin - 34 seconds ago